Shares of Simulations Plus, Inc. (NASDAQ:SLP – Get Free Report) have been given a consensus recommendation of “Hold” by the nine ratings firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, seven have issued a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price among analysts that have covered the stock in the last year is $20.90.
SLP has been the subject of a number of research analyst reports. TD Cowen dropped their price target on Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 10th. Weiss Ratings upgraded Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a research report on Friday, June 5th. Craig Hallum cut Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price target for the company. in a research report on Thursday. Wall Street Zen cut Simulations Plus from a “buy” rating to a “hold” rating in a research report on Saturday, June 13th. Finally, William Blair cut Simulations Plus from an “outperform” rating to a “market perform” rating in a research report on Wednesday.
Read Our Latest Research Report on Simulations Plus
Institutional Trading of Simulations Plus
Simulations Plus Price Performance
Shares of NASDAQ SLP opened at $18.24 on Tuesday. The stock has a fifty day moving average price of $15.34 and a 200 day moving average price of $15.60. Simulations Plus has a 1-year low of $11.09 and a 1-year high of $21.01. The company has a market cap of $368.45 million, a PE ratio of -5.83 and a beta of 1.33.
Simulations Plus (NASDAQ:SLP – Get Free Report) last released its quarterly earnings data on Thursday, April 9th. The technology company reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.08. The firm had revenue of $24.29 million during the quarter, compared to analysts’ expectations of $21.66 million. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%. Analysts anticipate that Simulations Plus will post 0.85 earnings per share for the current fiscal year.
Simulations Plus Company Profile
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.
Recommended Stories
- Five stocks we like better than Simulations Plus
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
